Renault K M, Carlsen E M, Hædersdal S, Nilas L, Secher N J, Eugen-Olsen J, Cortes D, Olsen S F, Halldorsson T I, Nørgaard K
Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Obstetric Clinic, JMC, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Int J Obes (Lond). 2017 Apr;41(4):598-605. doi: 10.1038/ijo.2017.9. Epub 2017 Jan 17.
Offspring of obese mothers have increased risk of developing obesity and related short- and long-term disease. The cause is multifactorial and may partly be explained by the unfavorable intrauterine environment. Intervention during pregnancy leading to a healthier lifestyle among obese may alter this.
To assess the effect of lifestyle intervention on markers of maternal metabolism and inflammation in 'the TOP (Treatment of Obese Pregnant Women) study', a randomized controlled trial.
In the TOP-study 425 participants with body mass index ⩾30 kg/m were randomized to intervention with dietary advices and physical activity assessed by pedometer (PA+D), physical activity assessed by pedometer (PA) or control (C). Of 389 participants completing the study 376 had available blood samples. Serum was analyzed for insulin, c-peptide, lipid profile, leptin, high-sensitivity CRP (hsCRP) and Soluble urokinase Plasminogen Activator Receptor (suPAR), in week 18-20 and 28-30, and simultaneously a 2-h oral glucose-tolerance-test was performed. Diet was assessed in gestational week 11-14 and 36-37 using a validated 360-item Food Frequency Questionnaire.
Median levels of hsCRP in gestational week 28-30 were lower in each of the intervention groups (8.3 mg/l in PA+D group, P=0.03; and 8.8 mg/l in PA group, P=0.02) versus the control group (11.5 mg/l). Obtaining 11 000 steps per day as aimed for resulted in a 21% lower hsCRP compared to non-compliant women. Women reporting high carbohydrate intake had around 30% higher hsCRP concentrations in late gestation than women reporting the lowest intake. There were no differences in lipid profile or any of the metabolic markers in gestational week 28-30 when comparing the intervention and control groups.
Lifestyle intervention in obese women can reduce hsCRP representing a marker of inflammation during pregnancy. The effect may partly be mediated by more physical activity and partly by changes in intake of carbohydrates and the glycaemic load.
肥胖母亲的后代患肥胖症及相关短期和长期疾病的风险增加。其原因是多方面的,部分原因可能是不利的子宫内环境。肥胖孕妇在孕期进行能带来更健康生活方式的干预可能会改变这种情况。
在一项随机对照试验“TOP(肥胖孕妇治疗)研究”中,评估生活方式干预对孕妇代谢和炎症标志物的影响。
在TOP研究中,425名体重指数≥30kg/m²的参与者被随机分为三组,分别接受饮食建议和通过计步器评估的体育活动干预(PA+D组)、通过计步器评估的体育活动干预(PA组)或对照组(C组)。在389名完成研究的参与者中,376人有可用的血液样本。在第18 - 20周和28 - 30周分析血清中的胰岛素、C肽、血脂谱、瘦素、高敏C反应蛋白(hsCRP)和可溶性尿激酶型纤溶酶原激活物受体(suPAR),同时进行2小时口服葡萄糖耐量试验。在妊娠第11 - 14周和36 - 37周使用经过验证的360项食物频率问卷评估饮食情况。
在妊娠第28 - 30周时,各干预组的hsCRP中位数水平均低于对照组(PA+D组为8.3mg/l,P = 0.03;PA组为8.8mg/l,P = 0.02),对照组为11.5mg/l。达到每天11000步目标的女性与未达标的女性相比,hsCRP降低了21%。报告高碳水化合物摄入量的女性在妊娠晚期的hsCRP浓度比报告最低摄入量的女性高约30%。在妊娠第28 - 30周比较干预组和对照组时,血脂谱或任何代谢标志物均无差异。
肥胖女性的生活方式干预可降低hsCRP,hsCRP是孕期炎症的一个标志物。这种效果可能部分由更多的体育活动介导,部分由碳水化合物摄入量和血糖负荷的变化介导。